FINWIRES · TerminalLIVE
FINWIRES

Raymond James Initiates SpyGlass Pharma at Outperform, With $39 Price Target

By

SpyGlass Pharma (SGP) has an average rating of buy and mean price target of $44, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Related Articles

Research

Wells Fargo Downgrades Bio-Techne to Equalweight From Overweight, Adjusts PT to $73 From $62

Bio-Techne (TECH) has an average rating of hold and mean price target of $70.09, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $72.25, Change: $+0.02, Percent Change: +0.03%

$TECH
Research

UBS Downgrades Coca-Cola Europacific Partners to Neutral From Buy, Adjusts PT to $107 From $109

$CCEP
Research

Citi Downgrades DHL Group to Neutral Rating, Lifts PT

Citi on Thursday downgraded German logistics company Deutsche Post (DHL.F), d/b/a DHL Group, to neutral from buy rating, while increasing its price target to 59 euros from 58 euros.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$DHL.F